BISPHOSPHONATE BONE QUALITY IN WOMEN WITH BREAST CANCER
乳腺癌女性双磷酸盐骨质量
基本信息
- 批准号:7285270
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-25 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:Alkaline PhosphataseAnimalsBiochemical MarkersBiochemistryBiomechanicsBiopsyBiopsy SpecimenBone DensityBone ResorptionBone SurfaceCancer PatientClinical ProtocolsDEXADataDepositionDiagnosisDichloromethylene DiphosphonateDiseaseDoseElectronsEnd PointEnrollmentFailureFluoridesFractureFrequenciesFundingHip region structureHumanIbandronateImageIncidenceIntravenousInvasiveKineticsLabelMeasurementMeasuresMental DepressionMetastatic Neoplasm to the BoneN-telopeptideNeoplasm MetastasisOralOsteogenesisOsteoidOsteoporosisPharmaceutical PreparationsPhysiologyPositron-Emission TomographyPostmenopausePremenopausePropertyProtocols documentationRandomizedRateResearchResearch PersonnelRoentgen RaysSerumSkeletal systemSkeletonSouthwest Oncology GroupStagingStressStructureSurfaceTechniquesTestingTetracyclineTetracyclinesThickTimeTissuesVertebral columnWidthWomanWorkX-Ray Computed TomographyZoledronatebisphosphonatebonebone healthbone imagingbone lossbone qualitybone strengthbone toughnessbone turnoverdaydensityimprovedmalignant breast neoplasmmineralizationpreventtime useuptake
项目摘要
DESCRIPTION (provided by applicant): Bisphosphonates may reduce the incidence of bone metastases in women with breast cancer, but survival data are inconsistent. The Southwest Oncology Group is therefore conducting a 3 year clinical protocol enrolling 6,000 women with randomization to clodronate, ibandronate or zoledronate to determine whether high doses of these bisphosphonates can prevent bone metastases and improve survival in women with breast cancer. The doses are two to ten times greater than those used to treat osteoporosis, and the effects of high-dose bisphosphonates on the bone health in these women are uncertain. Animal studies have shown that high-dose bisphosphonates caused microdamage accumulation and abnormal material properties of the bone. The breast cancer study provides an exceptional opportunity to evaluate bisphosphonate-induced changes in bone quality and bone physiology in humans. The hypothesis is that high-dose bisphosphonate therapy will result in profound depression of bone resorption and formation, increased mineralization density and decreased intrinsic toughness of the bone. For this proposal, a subset of 90 premenopausal women will undergo tetracycline-labeled iliac crest bone biopsies, bone density measurements by dual x ray absorptimetry and serum biochemical markers of bone turnover before and after bisphosphonate treatment. The bone will be measured with micro-computed tomography for structural parameters including connectivity, bone volume, and cortical thickness. Biomechanical testing in compression will determine the stiffness (Young's modulus), yield point, toughness and strength. Histomorphometric measurements of bone surfaces will allow calculations of bone formation rates and activation frequency. Mineralization density will be measured using backscattered electron imaging. A subset of 27 women will undergo kinetic analysis of fluoride deposition in bone by 18-Fluoride PET scans. Results of the study will provide valuable information about skeletal effects of high-dose bisphosphonates in humans.
描述(由申请人提供):双膦酸盐可能会降低乳腺癌女性骨转移的发生率,但生存数据不一致。因此,西南肿瘤学组正在进行3年的临床方案,该方案招募了6,000名具有随机分配给氯膦酸盐,i灯膦酸盐或唑来膦酸盐的女性,以确定高剂量的这些双膦酸盐是否可以防止骨转移酶并改善乳腺癌女性的生存率。剂量比治疗骨质疏松症的剂量大2到十倍,而高剂量双膦酸盐对这些女性骨骼健康的影响尚不确定。动物研究表明,高剂量的双膦酸盐会导致骨骼的微塑料积累和异常的材料特性。乳腺癌研究为评估双膦酸盐诱导的人类骨质和骨生理变化提供了极大的机会。假设是,高剂量的双膦酸盐治疗将导致骨吸收和形成,矿化密度增加和骨骼内在韧性降低。对于这一提议,一部分90个绝经前女性将接受四环素标记的iLiac Crest骨活检,双X射线吸收率和血清生化标记在双膦酸盐治疗前后,骨密度测量以及血清生化标志物。骨头将用微型层析成像测量,用于结构参数,包括连通性,骨骼体积和皮质厚度。压缩中的生物力学测试将决定刚度(Young的模量),产量点,韧性和强度。骨表面的组织形态测量结果将允许计算骨形成速率和激活频率。矿化密度将使用反向散射的电子成像测量。 27名妇女的子集将通过18-氟化物PET扫描对骨中的氟化物沉积进行动力学分析。该研究的结果将提供有关大剂量双膦酸盐在人类中的骨骼影响的有价值信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSAN M OTT其他文献
SUSAN M OTT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUSAN M OTT', 18)}}的其他基金
BISPHOSPHONATE BONE QUALITY IN WOMEN WITH BREAST CANCER
乳腺癌女性双磷酸盐骨质量
- 批准号:
7471563 - 财政年份:2005
- 资助金额:
-- - 项目类别:
BISPHOSPHONATE BONE QUALITY IN WOMEN WITH BREAST CANCER
乳腺癌女性双磷酸盐骨质量
- 批准号:
7665556 - 财政年份:2005
- 资助金额:
-- - 项目类别:
BISPHOSPHONATE BONE QUALITY IN WOMEN WITH BREAST CANCER
乳腺癌女性双磷酸盐骨质量
- 批准号:
7124686 - 财政年份:2005
- 资助金额:
-- - 项目类别:
BISPHOSPHONATE BONE QUALITY IN WOMEN WITH BREAST CANCER
乳腺癌女性双磷酸盐骨质量
- 批准号:
6967087 - 财政年份:2005
- 资助金额:
-- - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
以秀丽隐杆线虫为例探究动物在不同时间尺度行为的神经基础
- 批准号:32300829
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
脊椎动物胚胎发育单细胞磷酸化蛋白质组高通量高灵敏度分析新技术新方法
- 批准号:22374084
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
新疆旱獭等啮齿动物携带病毒的病原学与病原生态学研究
- 批准号:32300424
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Leveraging mouse and human models to investigate neuroprotective effects of blood-derived exerkines in Alzheimer's disease
利用小鼠和人类模型研究血液来源的运动因子对阿尔茨海默病的神经保护作用
- 批准号:
10901031 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Noninvasive Monitoring of Hepatic Glutathione Depletion Through Blood Test
通过血液检测无创监测肝脏谷胱甘肽消耗情况
- 批准号:
10230423 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Noninvasive Monitoring of Hepatic Glutathione Depletion Through Blood Test
通过血液检测无创监测肝脏谷胱甘肽消耗情况
- 批准号:
10552664 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Noninvasive Monitoring of Hepatic Glutathione Depletion Through Blood Test
通过血液检测无创监测肝脏谷胱甘肽消耗情况
- 批准号:
10377423 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Development of an engineered CCL20 protein as a lead therapeutic molecule for psoriasis
开发工程化 CCL20 蛋白作为银屑病的主要治疗分子
- 批准号:
10263914 - 财政年份:2018
- 资助金额:
-- - 项目类别: